A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Study will evaluate the pharmacokinetics (PK), safety and tolerability of a single 10 mg dose
of lorcaserin hydrochloride in obese pediatric subjects 6 to 11 years of age.